MHRA Drug Safety Update: April 2024
Tuesday 30th April 2024
A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 9 April 2024) has been published and includes articles on:
- Finasteride: reminder of the risk of psychiatric side effects and of sexual side effects (which may persist after discontinuation of treatment)
- Montelukast: reminder of the risk of neuropsychiatric reactions
- Letters and medicine recalls sent to healthcare professionals in April 2024.
To see the latest MHRA Drug Safety Updates in full, visit the GOV.uk website.
Tuesday 30th April 2024
